Tofflon Science and Technology Group Co Ltd. Stock Analysis 300171.SZ

Tofflon Science & Technology Group Co. Ltd. engages in the research, development, design, manufacture, distribution of pharmaceuticals equipment. The company is headquartered in Shanghai, Shanghai and currently employs 5,479 full-time employees. The company went IPO on 2011-02-01. The firm mainly operates four businesses. The bioprocessing business mainly provides equipment, instruments, and consumables such as fermentation systems, precision packaging systems, and traditional Chinese medicine extraction systems. The pharmaceutical preparations business mainly provides equipment and instruments required for the preparation of injectable dosage forms, oral solid dosage forms, and the inspection and packaging of finished drugs. The integrated engineering solutions business mainly provides information system software and intelligent manufacturing integrated solutions. The food engineering business is mainly engaged in the manufacturing of equipment for the liquid food sector, and the provision of system solutions, process engineering, and overall solutions.